Charles Schwab
CDMO

Charles Schwab’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Charles Schwab’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-520,598
Closed -$6.43M – 3534
2024
Q4 		$6.43M Buy
520,598
+7,022
+1% +$80.4K ﹤0.01% 2225
2024
Q3 		$5.84M Buy
513,576
+8,324
+2% +$83.5K ﹤0.01% 2284
2024
Q2 		$3.61M Buy
505,252
+8,798
+2% +$67.3K ﹤0.01% 2502
2024
Q1 		$3.33M Buy
496,454
+10,125
+2% +$69.7K ﹤0.01% 2440
2023
Q4 		$3.16M Sell
486,329
-4,677
-1% -$30.1K ﹤0.01% 2496
2023
Q3 		$4.64M Buy
491,006
+12,553
+3% +$151K ﹤0.01% 2295
2023
Q2 		$6.68M Buy
478,453
+7,714
+2% +$131K ﹤0.01% 2100
2023
Q1 		$8.83M Buy
470,739
+4,672
+1% +$76.7K ﹤0.01% 1932
2022
Q4 		$6.42M Buy
466,067
+17,462
+4% +$267K ﹤0.01% 2078
2022
Q3 		$8.58M Buy
448,605
+11,925
+3% +$217K ﹤0.01% 1936
2022
Q2 		$6.66M Sell
436,680
-6,322
-1% -$93.5K ﹤0.01% 2050
2022
Q1 		$9.02M Sell
443,002
-22,619
-5% -$461K ﹤0.01% 2010
2021
Q4 		$13.6M Buy
465,621
+9,864
+2% +$282K ﹤0.01% 1835
2021
Q3 		$9.83M Buy
455,757
+307,747
+208% +$7.43M ﹤0.01% 2015
2021
Q2 		$3.8M Sell
148,010
-870
-0.6% -$18.6K ﹤0.01% 2477
2021
Q1 		$2.71M Buy
148,880
+11,873
+9% +$197K ﹤0.01% 2564
2020
Q4 		$1.58M Buy
137,007
+6,396
+5% +$58.5K ﹤0.01% 2660
2020
Q3 		$996K Sell
130,611
-5,335
-4% -$40.4K ﹤0.01% 2679
2020
Q2 		$893K Buy
135,946
+42
+0% +$234 ﹤0.01% 2656
2020
Q1 		$695K Buy
135,904
+3,580
+3% +$21.7K ﹤0.01% 2596
2019
Q4 		$1.01M Sell
132,324
-8,410
-6% -$49.1K ﹤0.01% 2592
2019
Q3 		$746K Hold
140,734
– – ﹤0.01% 2653
2019
Q2 		$789K Buy
140,734
+37,480
+36% +$155K ﹤0.01% 2655
2019
Q1 		$439K Sell
103,254
-6,246
-6% -$25.5K ﹤0.01% 2806
2018
Q4 		$449K Hold
109,500
– – ﹤0.01% 2805
2018
Q3 		$752K Buy
109,500
+15,000
+16% +$88.9K ﹤0.01% 2706
2018
Q2 		$371K Buy
+94,500
New +$328K ﹤0.01% 2892
2016
Q2 		– Sell
-55,529
Closed -$164K – 3144
2016
Q1 		$164K Buy
55,529
+19,086
+52% +$102K ﹤0.01% 2940
2015
Q4 		$299K Hold
36,443
– – ﹤0.01% 2864
2015
Q3 		$261K Hold
36,443
– – ﹤0.01% 2879
2015
Q2 		$335K Hold
36,443
– – ﹤0.01% 2829
2015
Q1 		$345K Hold
36,443
– – ﹤0.01% 2781
2014
Q4 		$355K Hold
36,443
– – ﹤0.01% 2774
2014
Q3 		$347K Hold
36,443
– – ﹤0.01% 2735
2014
Q2 		$480K Hold
36,443
– – ﹤0.01% 2641
2014
Q1 		$485K Buy
36,443
+8,514
+30% +$112K ﹤0.01% 2602
2013
Q4 		$272K Hold
27,929
– – ﹤0.01% 2847
2013
Q3 		$274K Sell
27,929
-11,328
-29% -$113K ﹤0.01% 2789
2013
Q2 		$369K Buy
+39,257
New +$411K ﹤0.01% 2648

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Charles Schwab's CDMO Position: Q1 2025 in Review

Charles Schwab sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 520,598 shares — an estimated $6.43M sold.

Charles Schwab first reported a position in CDMO in Q2 2013 and held it in 39 quarters. The position peaked at $13.6M in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Charles Schwab reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Charles Schwab sold 520,598 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $6.43M.
  • Charles Schwab first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 39 quarters.
  • Charles Schwab's Avid Bioservices, Inc. Common Stock position peaked at $13.6M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.